Friday, February 26, 2021
  • Markets & Companies
    • Stock Market
    • Companies
    • Appointments
    • Commodities
  • Business & Economy
    • Energy
    • Agricultural Economy
    • Insurance & Pensions
    • Aviation
    • Maritime
    • Road Transport
    • Financial Inclusion
    • Investment
    • Manufacturing
    • Consumer Goods
  • Innovation
  • MSME
  • Empire
  • Opinion
  • Cultural Currents
  • Features
  • AE Magazine
  • Corporate Rendezvous
Financial Street is a meeting point for technology, economy, and journalism.
No Result
View All Result
  • Markets & Companies
    • Stock Market
    • Companies
    • Appointments
    • Commodities
  • Business & Economy
    • Energy
    • Agricultural Economy
    • Insurance & Pensions
    • Aviation
    • Maritime
    • Road Transport
    • Financial Inclusion
    • Investment
    • Manufacturing
    • Consumer Goods
  • Innovation
  • MSME
  • Empire
  • Opinion
  • Cultural Currents
  • Features
  • AE Magazine
  • Corporate Rendezvous
Financial Street is a meeting point for technology, economy, and journalism.
No Result
View All Result

GSK, Novartis support Africa’s scientific research with $3.6m grant

by Ehime Alex
January 20, 2021
in Markets & Companies
0
GSK, Novartis support Africa's scientific research with $3.6m grant
0
SHARES
18
VIEWS
Share on FacebookShare on TwitterShare on LinkedInShare on WhatsApp

READ ALSO

Bears return as investors lost N66bn

Shareholders to sell 25% Ellah Lakes’ shares

GSK and Novartis have called on African researchers to submit research proposals on the relevance of African genetic diversity to the treatment of malaria and tuberculosis.

The ‘Project Africa Genomic Research Approach for Diversity and Optimising Therapeutics’ comes with a combined funding commitment of $3.6 million over five years, Novartis said in a statement on Tuesday.

The combined effort will support high-quality scientific research investigating the link between genetic diversity across different regions in Africa and its potential impact on response to drug therapeutics.

Read Also:

  • Lessons from Mexico: Pushing for better, faster O&G project implementation in Africa
    Lessons from Mexico: Pushing for better, faster O&G…
  • Safeguarding LNG operations in Mozambique
    Safeguarding LNG operations in Mozambique
  • Retracing Republic of South Sudan’s alliances
    Retracing Republic of South Sudan’s alliances

“Novartis has a long-standing commitment to improving and extending the lives of patients around the world.  Our efforts include seeking innovative ways to improve the standard of care where possible. This is why we are excited by this important collaboration on scientific research on genetic diversity in Africa.

“It has the potential to improve the efficacy and tolerability of current and future medicines, starting with two of the most deadly diseases, malaria and tuberculosis,” Chief Operating Officer for Global Health at Novartis, Lutz Hegemann, said.

Also commenting on the project, Senior Vice President Global Health Pharma at GSK, Pauline Williams, explained, “At GSK, human genetics is a core pillar of our research and development strategy. Genetic diversity is greater in Africa than in any other continental population resulting in some African patients having varying responses to treatments.

“We are excited to launch Project Africa GRADIENT which aims to catalyse the best science in the continent to optimise treatment responses for malaria and tuberculosis, two infectious diseases that disproportionately affect African populations.”

The project’s funding mechanisms include fellowships, investigator-sponsored research, and seed-fund and will give priority to research aimed at collecting data from currently under-represented regions.

close
Subscribe to our newsletter and join thousands of readers of our financial, economic & investments news blog!
We don't spam with your email

Check your inbox or spam folder to confirm your subscription.

  • Facebook
  • Twitter
  • Pinterest
  • LinkedIn

Tags: AfricaGSKNovartScientific research

Get real time update about this post categories directly on your device, subscribe now.

Unsubscribe

Related Posts

Investors lose N74.4bn on sustained bearish activity
Markets & Companies

Bears return as investors lost N66bn

February 26, 2021
Shareholders to sell 25% Ellah Lakes’ shares
Markets & Companies

Shareholders to sell 25% Ellah Lakes’ shares

February 25, 2021
M’East Africa’s annual food imports to hit $170bn
Commodities

Nigeria allays fears of stockfish import

February 25, 2021
Financial Street - NSE to host 4th edition of equities market data workshop
Markets & Companies

Nigeria’s equities advance further by 0.14%

February 25, 2021
PIDG, EAIF supports Senegal’s local currency bond issue
Markets & Companies

Group commits $50m to Africa’s digital infrastructure

February 24, 2021
Nestlé S.A. acquires N747.54m stake in Nigeria’s subsidiary
Markets & Companies

TEI certifies Nestle top employer in Central, West Africa

February 23, 2021
Next Post
Remarks of AfDB president, Adesina, at CIBN fellowship investiture

AfCFTA: Adesina honoured for leadership role

RECENT STORIES

Investors lose N74.4bn on sustained bearish activity

Bears return as investors lost N66bn

February 26, 2021
M-Net launches pop-up channel

M-Net launches pop-up channel

February 25, 2021
Customs nabs 44 suspects, intercepts cars, others worth N30bn

Customs intercepts Tramadol worth N223m at Apapa

February 25, 2021
Freight forwarders protest delay in cargo clearance at Kirikiri

NPA, shippers, others join forces for onboard cargo inspection

February 25, 2021
Access Bank begins accelerator programme with N10m

Access Bank begins accelerator programme with N10m

February 25, 2021
Equatorial Guinea, African Energy Chamber meet on energy developments amid COVID-19

Angola mulls increased transparency oil block licensing

February 25, 2021
Shouldering the burden of fuel subsidy removal

Tradex opens first fuel station in E’Guinea

February 25, 2021

TRENDING

  • Seven banks’ grow assets byN3.58tnamid COVID-19 crisis

    CIBN’s mentoring scheme critical to banking sector – Stakeholders

    2 shares
    Share 0 Tweet 0
  • W’Bank projects $1.6bn vaccine roll-out aid by March

    2 shares
    Share 0 Tweet 0
  • First Bank CEO: SMEs key to Nigeria’s economic growth

    2 shares
    Share 0 Tweet 0
  • Nigeria’s equities advance further by 0.14%

    0 shares
    Share 0 Tweet 0
  • United Capital posts 57% growth

    2 shares
    Share 0 Tweet 0
Financial Street is a meeting point for technology, economy, and journalism.

© Financial Street 2020. All Rights Reserved.

More Links

  • Privacy Policy
  • Terms of Use
  • Contact Us

Follow Us

No Result
View All Result
  • Markets & Companies
    • Stock Market
    • Companies
    • Appointments
    • Commodities
  • Business & Economy
    • Energy
    • Agricultural Economy
    • Insurance & Pensions
    • Aviation
    • Maritime
    • Road Transport
    • Financial Inclusion
    • Investment
    • Manufacturing
    • Consumer Goods
  • Innovation
  • MSME
  • Empire
  • Opinion
  • Cultural Currents
  • Features
  • AE Magazine
  • Corporate Rendezvous